Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer

This study explored the clinical implications of tumor mutational burden (TMB) in a well-defined HER2-positive metastatic breast cancer (MBC) patient population who had been previously treated but had subsequent disease progression. Whole exome sequencing was performed on formalin-fixed paraffin-emb...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncoimmunology
Autors principals: Park, Song Ee, Park, Kyunghee, Lee, Eunjin, Kim, Ji-Yeon, Ahn, Jin Seok, Im, Young-Hyuck, Lee, Choonghoon, Jung, Hun, Cho, Soo Youn, Park, Woong-Yang, Cristescu, Razvan, Park, Yeon Hee
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6136852/
https://ncbi.nlm.nih.gov/pubmed/30221068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1466768
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars